This renewal application requests continued funding of a predoctoral training program in cellular and molecular biology at Yale University. Since its inception in 1975, the goal of the program has been to provide trainees with both a strong intellectual foundation through coursework and rigorous experimental training in research areas that take molecular and mechanistic approaches to a broad range of basic biological problems. Students and faculty participating in this training program are from several departments, including the main undergraduate campus and the School of Medicine. Thus, the training program fosters connections that transcend departmental boundaries. Much of the research carried out by our students has clear relevance to human health and disease. Students supported by the training program will be in their first, second, or third year of graduate school. The students arrive at Yale as members of the campus-wide Combined Program in the Biological and Biomedical Sciences (BBS). They come with a range of backgrounds in biology, biochemistry, chemistry, genetics, molecular biology and physics, and all students have had significant research experience before graduate school. In their first year, students will take courses that provide general knowledge in disciplines related to cellular and molecular biology and a conceptual grounding for critical evaluation of research design and methods. Students will also carry out research rotations in at least three laboratories selected according to their research interests. By the end of the first year, students will choose their thesis research advisor and affiliate with an appropriate academic department. During the second year, academic requirements for candidacy in the Ph.D. degree will be completed, including a qualifying exam in which the student prepares and defends a thesis proposal. By the third year, a thesis advisory committee will be assembled to guide each student to the completion of his or her Ph.D. training. Teaching experience is an essential part of training, and all students teach with supervision and guidance from the faculty. The average time to graduation is six years.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Gindhart, Joseph G
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Schools of Medicine
New Haven
United States
Zip Code
Price, Nathan L; Singh, Abhishek K; Rotllan, Noemi et al. (2018) Genetic Ablation of miR-33 Increases Food Intake, Enhances Adipose Tissue Expansion, and Promotes Obesity and Insulin Resistance. Cell Rep 22:2133-2145
St Gelais, Corine; Kim, Sun Hee; Maksimova, Victoria V et al. (2018) A Cyclin-Binding Motif in Human SAMHD1 Is Required for Its HIV-1 Restriction, dNTPase Activity, Tetramer Formation, and Efficient Phosphorylation. J Virol 92:
Vincent, Nicholas G; Charette, J Michael; Baserga, Susan J (2018) The SSU processome interactome in Saccharomyces cerevisiae reveals novel protein subcomplexes. RNA 24:77-89
Ricciardi, Adele S; Bahal, Raman; Farrelly, James S et al. (2018) In utero nanoparticle delivery for site-specific genome editing. Nat Commun 9:2481
Ogawa, Lisa M (2018) On the Opioid Crisis and the Future of Pain Treatment: An Interview with Bertha K. Madras, PhD. Yale J Biol Med 91:73-78
Kudalkar, Shalley N; Beloor, Jagadish; Quijano, Elias et al. (2018) Reply to Pandey et al.: Understanding the efficacy of a potential antiretroviral drug candidate in humanized mouse model of HIV infection. Proc Natl Acad Sci U S A 115:E8114-E8115
Buzovetsky, Olga; Tang, Chenxiang; Knecht, Kirsten M et al. (2018) The SAM domain of mouse SAMHD1 is critical for its activation and regulation. Nat Commun 9:411
Ogawa, Lisa M; Burford, Neil T; Liao, Yu-Hsien et al. (2018) Discovery of Selective Cannabinoid CB2 Receptor Agonists by High-Throughput Screening. SLAS Discov 23:375-383
Iwamoto, Daniel V; Huehn, Andrew; Simon, Bertrand et al. (2018) Structural basis of the filamin A actin-binding domain interaction with F-actin. Nat Struct Mol Biol 25:918-927
Knecht, Kirsten M; Buzovetsky, Olga; Schneider, Constanze et al. (2018) The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1. Proc Natl Acad Sci U S A 115:E10022-E10031

Showing the most recent 10 out of 511 publications